Stock Market Summary – December 19, 2025

Major pharma companies, including Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche’s Genentech, Boehringer Ingelheim and Novartis, have agreed to lower drug prices under a deal with President Trump. In a significant pledge, Bristol Myers Squibb will offer their top-prescribed product, Eliquis, for free to Medicaid.

In stock market news, Citi resumed coverage of AI computing provider CoreWeave with a buy rating and a $135 price target, doubling yesterday’s close. OpenAI is set to reach a valuation of $830 billion in the midst of another funding round. Nike’s shares, however, dropped 11% following a challenging quarter in China despite progress in its North American operations.

Wells Fargo favored Walmart over Costco, raising its price target on the former and cutting the latter. Meanwhile, Morgan Stanley raised targets on Dollar General and Dollar Tree. FedEx’s stocks increased following a strong quarterly report.

Jim Cramer suggests buying Nike’s post-earnings fall stocks, projecting a value of $100 per stock. Despite disappointing results in China, North American sales exceeded expectations. In other news, stocks of fry producer Lamb Weston saw a 25% fall while cloud provider CoreWeave surged by 20%, and Nike shares dropped by 10%.

Bank of America’s Bull & Bear indicator showed a potential downward trend for stocks, signaling investors to sell. In real estate, November home sales were stalling due to high prices, increasing mortgage rates, and decreased supply.

Finally, Oracle’s stocks jumped 7% upon joining a group designated to lead TikTok’s U.S. operations. The cloud provider’s participation in the investor group helped prevent the platform from being banned under U.S. national security concerns. In a separate event, Capital One Financial’s shares sold at a considerable profit. Lyft’s success, however, is expected to be short-lived due to threats from the autonomous vehicles market.